1. A novel modular platform for adoptive T cell therapy combining bispecific antibodies with synthetic agonistic receptors. (March 2019) Authors: Karches, C.H.; Benmebarek, M.; Schmidbauer, M.L.; Kurzay, M.; Klaus, R.; Lesch, S.; Cadilha, B.; Rataj, F.; Heise, C.; Geiger, M.; Murr, R.; Berg, J.vom; Jastroch, M.; Lamp, D.; Duewell, P.; Niederfellner, G.; Sustmann, C.; Endres, S.; Klein, C.; Kobold, S. Journal: European journal of cancer Issue: Volume 110(2019)Supplement 1 Page Start: S25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Characterization of bispecific antibodies that drive synthetic agonistic receptor - transduced T cells to mediate specific and conditional therapy in human pancreatic cancer models. (March 2019) Authors: Benmebarek, M.; Karches, C.H.; Schmidbauer, M.L.; Kurzay, M.; Klaus, R.; Geiger, M.; Rataj, F.; Cadilha, B.; Lesch, S.; Heise, C.; Murr, R.; Berg, J.vom; Jastroch, M.; Lamp, D.; Niederfellner, G.; Sustmann, C.; Endres, S.; Klein, C.; Kobold, S. Journal: European journal of cancer Issue: Volume 110(2019)Supplement 1 Page Start: S3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗